Age > 75 years, warfarin
Age > 75 years, warfarin. Stroke/SE on rivaroxaban or warfarin, in patients younger or older than 75 years old (ROCKET-AF). Age < 75 years, warfarin. Age > 75 years, rivaroxaban. Age < 75 years, rivaroxaban. Estimated cumulative probability of stroke/SE (%).
190 views • 1 slides